A New Team

Genentech and 23andMe are collaborating on a study to determine genetic influences on how breast cancer patients respond to bevacizumab, also known as Avastin, reports Erika Check Hayden at the Nature News blog. She adds that FDA recently revoked the approval for Avastin to be used to treat certain breast cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.